logo
Could you keep your mobile in another room? Brits reveal how they're overcoming smartphone ‘addiction'

Could you keep your mobile in another room? Brits reveal how they're overcoming smartphone ‘addiction'

Scottish Sun12-07-2025
More people are looking to reduce their screen time
PHONE DOWN Could you keep your mobile in another room? Brits reveal how they're overcoming smartphone 'addiction'
ONE in three adults have tried to end their "addiction" to their phones through a digital detox with methods including keeping it in a different room, setting a digital curfew, and deleting social media apps.
A poll of 2,000 adults found 41 per cent look at their mobiles "too much" - with 54 per cent doing so for three hours or more every day.
Advertisement
2
One method Brits are trying is taking on 'quiet hobbies'
Credit: Getty
But 19 per cent feel this is an unfulfilling use of time.
As a result, 35 per cent have reduced, or are attempting to reduce, screentime or end it completely.
Other methods to digitally detox and cut back on phone use include practising "quiet hobbies", with the most popular screen-free activities including reading (41 per cent), walking (35 per cent), socialising with friends (24 per cent) and gardening (21 per cent).
Some have even turned to playing board games to fill their time instead.
Advertisement
Kellie Wyles from DFS, which commissioned the research, said: "There is certainly more to life than our phones and being more present in the moment is key for improving mental health.
'We live in an era where FOMO is a common part of society, so people are keen to get news and updates as and when they happen – but this can cause them to miss out on valuable downtime.'
The study also found 14 per cent of those who feel they spend excessive time on their phone have done so for more than 11 years.
But since reducing their screen time, 71 per cent have noticed their mental health improve.
Advertisement
Better sleep (47 per cent), feeling more present (45 per cent), and calmer (42 per cent) are some of the benefits Brits have noticed since putting their phone down.
While 18 per cent have even found they have made less errors since reducing their screentime.
Despite this, 30 per cent admitted they would feel most panicked about losing their phone, over a wallet/purse (23 per cent) and house keys (18 per cent).
With worries about banking apps (65 per cent) representing the biggest concern.
Advertisement
It also emerged that 46 per cent of Brits feel life was better before smartphones.
To tackle their phone addictions, 13 per cent have introduced digital-free zones in their homes, with another 39 per cent claiming they haven't yet but would consider introducing one in the future.
Creating a calming environment is also a priority, with over half (54 per cent) opting for comfortable furniture, 35 per cent choosing calming neutral tones, 29 per cent incorporating more houseplants, and 28 per cent enhancing their spaces with mood lighting.
Meanwhile, one in four of those polled, via OnePoll, have a dedicated space for "quiet hobbies", with the most common being a reading nook (48 per cent), closely followed by meditation areas (37 per cent) and a table for board games or puzzles (34 per cent).
Advertisement
DFS took to the streets of London with presenter Lisa Snowdon who invited Brits to take a seat on her sofa and share how they're switching off from screens.
The video interviews revealed a growing trend of people actively taking steps to digitally detox, from leaving their phones in another room to creating digital-free zones in their homes.
Echoing the research, Lisa discovered that many are embracing simple, grounding activities like walking, cooking and spending quality time with loved ones - all in a bid to reconnect with the present moment and reduce screen time.
Kellie Wyles added: 'Quiet hobbies are what keeps us grounded in the moment and appreciating the simple things in life.
Advertisement
'We can often get carried away with what is going on elsewhere and neglect the beauty of simply taking time out.
'These moments of calm are often best enjoyed in the comfort of our homes so it's worth investing in creating a space that encourages relaxation, creativity and connection.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Common drug may speed up ageing, study finds
Common drug may speed up ageing, study finds

Metro

time4 hours ago

  • Metro

Common drug may speed up ageing, study finds

Hiyah Zaidi Published July 17, 2025 10:27am Link is copied Comments Taking a common drug which acts on the nervous system could be leading to faster ageing in older adults, a new study says. Published in the journal JAMA Open Network, the researchers concluded that a high exposure to anticholinergic drugs - used in flu medicine, and to relieve motion sickness and histamine reactions - could lead to a faster decline in physical performance in older age (Picture: Getty) Anticholinergic drugs are also used to treat chronic obstructive pulmonary disease, bladder illnesses and Parkinson's. They work by blocking the action of the nerve-to-nerve signalling molecule acetylcholine, which plays a key role in the functioning of the nervous system. They affect several major bodily functions. However, by discontinuing use, the sedative and cognitive adverse effects can be reversed (Picture: Getty) Anticholinergics are common. They are used to reduce cold and flu symptoms, (diphenhydramine/Benadryl), relieve motion sickness and histamine reactions (promethazine/Phenergan) and relax the bladder to limit needing the toilet all the time (oxybutynin/Ditropan). They're also used to relieve muscle stiffness in Parkinson's disease sufferers and even used as a common sleep aid (Picture: Getty) Anticholinergics can be used to dull an important neurotransmitter for thinking, muscle control and memory, known as acetylcholine. But past studies have revealed that by dulling it, a person can experience confusion, drowsiness, dizziness and weakness, and over time, these symptoms can turn into chronic issues with memory and movement. The latest study wanted to look at the effects of constant exposure to the drugs over a decade – while looking at intensity, duration and timing of past intake (Picture: Getty) The researchers looked at the changes in walking speed and grip strength in over 4,000 older adults over time and compared this with their exposure to anticholinergic medications based on data collected from February 1994 to March 2020. Their study focused on older people, so the average baseline for the men and women was 74.3 years, with follow-up assessments around eight years later (Picture: Getty) They found that while grip strength appeared unaffected, a higher exposure to anticholinergics was linked to a greater decline in walking speed, especially in people who had taken these drugs in what would be deemed clinically conventional, so more than 1,096 daily doses over 10 years. Frailty and changes in balance and gait are linked to multiple measures of poor health outcomes, including disability and mortality. However, they also found that those who met that 1,096 daily-dose threshold in the previous six years were found to have a much higher likelihood of weakened grip as well as slower walking pace (Picture: Getty) The researchers do not advise steering clear of anticholinergics completely, but ask people to be mindful of long-term use. They said: 'Anticholinergics are associated with numerous adverse outcomes in older adults; therefore, it is essential for clinicians to avoid their use when possible, prescribe the lowest effective dose, and periodically reevaluate patients to identify de-prescribing opportunities to minimize potential harms' (Picture: Getty) Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.

UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of
UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of

Scotsman

time6 hours ago

  • Scotsman

UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of

It comes as obesity affects over 1 in 4 adults in the UK | Shutterstock Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss treatments as a quarter of Brits battle obesity. Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Happy Pharmacy, an online UK-based pharmacy, is urging the media, healthcare providers, and the public to help dismantle the stigma around prescription weight loss injections. It comes as obesity affects over 1 in 4 adults in the UK - and more people are turning to medically approved treatments to support weight loss under professional supervision. Recent advances in weight loss injections, including Mounjaro® (tirzepatide) and Wegovy® (semaglutide) are shifting perceptions and offering new hope to individuals struggling with weight-related health issues. Palvinder Deol, Superintendent Pharmacist at Happy Pharmacy , said: 'Medications like Mounjaro and Wegovy give people the opportunity to take control of their health in a safe, evidence-based way. 'Obesity is a complex condition involving more than just diet and people deserve support, not judgment, when seeking help.' According to guidance from the National Institute for Health and Care Excellence (NICE) patients with a BMI of 35 or above, or 30+ with weight-related complications, such as high blood pressure or joint problems, may be eligible for these medications as confirmed by NHS England. 'We need to reframe weight loss support as a legitimate medical need,' Palvinder adds. 'When treatments are clinically indicated, patients should feel confident in pursuing them just as they would for any other health condition.' Both medications must be prescribed by a qualified healthcare professional following a full clinical assessment. They are not suitable for everyone, and are only offered to individuals who meet the eligibility criteria outlined by NICE and the MHRA. Following their regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) in late 2023, these treatments are being increasingly prescribed as part of structured weight management programmes across the country. Patients with a BMI of 35 or above, or 30+ with weight-related complications, may be eligible for these medications as confirmed by NHS England | Shutterstock 'We need to reframe weight loss support as a legitimate medical need' Happy Pharmacy, which launched in March 2025, provides a holistic online service offering treatments for weight loss, hair loss, and erectile dysfunction through pharmacist-led consultations. The goal of treatment is not cosmetic enhancement but to reduce long-term risks associated with conditions such as type 2 diabetes, cardiovascular disease, and obstructive sleep apnoea. Despite this clinical backing, Happy Pharmacy reports that many patients hesitate to pursue treatment due to lingering stigma and misinformation about obesity and medical intervention. Despite clinical studies supporting the efficacy of these medications. In a 72-week trial , Mounjaro users lost an average of 20% of their body weight. While participants prescribed Wegovy experienced a 15% reduction in body weight during the same timeframe. Observational data also suggests these treatments may deliver broader health benefits, including lowered risks of stroke and dementia in patients with type 2 diabetes. Beyond health improvements, weight loss injections may also offer economic relief. According to Happy Pharmacy's internal Food Savings Calculator , patients using appetite-suppressing medications could save up to £300 per month on food costs, depending on previous eating patterns. About Happy Pharmacy Happy Pharmacy is a UK-registered and fully regulated online pharmacy with over 10 years of experience in safely dispensing prescription medications nationwide. The service offers convenient access to licensed treatments following consultation with a healthcare professional. Palvinder Deol, BPharm (Hons), is a GPhC‑registered pharmacist with over 25 years of experience. His clinical and educational expertise spans pharmacy practice, weight loss medicines, and patient care. He currently serves as Superintendent Pharmacist ( Happy Pharmacy ).

UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of
UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of

Scotsman

time9 hours ago

  • Scotsman

UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of

It comes as obesity affects over 1 in 4 adults in the UK | Shutterstock Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss treatments as a quarter of Brits battle obesity. Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Happy Pharmacy, an online UK-based pharmacy, is urging the media, healthcare providers, and the public to help dismantle the stigma around prescription weight loss injections. It comes as obesity affects over 1 in 4 adults in the UK - and more people are turning to medically approved treatments to support weight loss under professional supervision. Recent advances in weight loss injections, including Mounjaro® (tirzepatide) and Wegovy® (semaglutide) are shifting perceptions and offering new hope to individuals struggling with weight-related health issues. Palvinder Deol, Superintendent Pharmacist at Happy Pharmacy , said: 'Medications like Mounjaro and Wegovy give people the opportunity to take control of their health in a safe, evidence-based way. 'Obesity is a complex condition involving more than just diet and people deserve support, not judgment, when seeking help.' According to guidance from the National Institute for Health and Care Excellence (NICE) patients with a BMI of 35 or above, or 30+ with weight-related complications, such as high blood pressure or joint problems, may be eligible for these medications as confirmed by NHS England. 'We need to reframe weight loss support as a legitimate medical need,' Palvinder adds. 'When treatments are clinically indicated, patients should feel confident in pursuing them just as they would for any other health condition.' Both medications must be prescribed by a qualified healthcare professional following a full clinical assessment. They are not suitable for everyone, and are only offered to individuals who meet the eligibility criteria outlined by NICE and the MHRA. Following their regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) in late 2023, these treatments are being increasingly prescribed as part of structured weight management programmes across the country. Patients with a BMI of 35 or above, or 30+ with weight-related complications, may be eligible for these medications as confirmed by NHS England | Shutterstock 'We need to reframe weight loss support as a legitimate medical need' Happy Pharmacy, which launched in March 2025, provides a holistic online service offering treatments for weight loss, hair loss, and erectile dysfunction through pharmacist-led consultations. The goal of treatment is not cosmetic enhancement but to reduce long-term risks associated with conditions such as type 2 diabetes, cardiovascular disease, and obstructive sleep apnoea. Despite this clinical backing, Happy Pharmacy reports that many patients hesitate to pursue treatment due to lingering stigma and misinformation about obesity and medical intervention. Despite clinical studies supporting the efficacy of these medications. In a 72-week trial , Mounjaro users lost an average of 20% of their body weight. While participants prescribed Wegovy experienced a 15% reduction in body weight during the same timeframe. Observational data also suggests these treatments may deliver broader health benefits, including lowered risks of stroke and dementia in patients with type 2 diabetes. Beyond health improvements, weight loss injections may also offer economic relief. According to Happy Pharmacy's internal Food Savings Calculator , patients using appetite-suppressing medications could save up to £300 per month on food costs, depending on previous eating patterns. About Happy Pharmacy Happy Pharmacy is a UK-registered and fully regulated online pharmacy with over 10 years of experience in safely dispensing prescription medications nationwide. The service offers convenient access to licensed treatments following consultation with a healthcare professional. Palvinder Deol, BPharm (Hons), is a GPhC‑registered pharmacist with over 25 years of experience. His clinical and educational expertise spans pharmacy practice, weight loss medicines, and patient care.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store